CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) LT-Debt-to-Total-Asset : 0.04 (As of Jun. 2018)

View and export this data going back to . Start your Free Trial

What is CTT Pharmaceutical Holdings LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. CTT Pharmaceutical Holdings's long-term debt to total assests ratio for the quarter that ended in Jun. 2018 was 0.04.

CTT Pharmaceutical Holdings's long-term debt to total assets ratio increased from Sep. 2016 (0.00) to Jun. 2018 (0.04). It may suggest that CTT Pharmaceutical Holdings is progressively becoming more dependent on debt to grow their business.

CTT Pharmaceutical Holdings LT-Debt-to-Total-Asset Historical Data

The historical data trend for CTT Pharmaceutical Holdings's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTT Pharmaceutical Holdings LT-Debt-to-Total-Asset Chart

CTT Pharmaceutical Holdings Annual Data

Trend

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

CTT Pharmaceutical Holdings Quarterly Data
	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Mar17	Jun17	Mar18	Jun18
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	-	-	0.04

CTT Pharmaceutical Holdings LT-Debt-to-Total-Asset Calculation

CTT Pharmaceutical Holdings's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2015 is calculated as

LT Debt to Total Assets (A: Dec. 2015 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2015 )	/	Total Assets (A: Dec. 2015 )
	=	0	/	0.644
	=

CTT Pharmaceutical Holdings's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2018 is calculated as

LT Debt to Total Assets (Q: Jun. 2018 )	=	Long-Term Debt & Capital Lease Obligation (Q: Jun. 2018 )	/	Total Assets (Q: Jun. 2018 )
	=	0.04	/	0.996
	=

CTT Pharmaceutical Holdings (OTCPK:CTTH) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

CTT Pharmaceutical Holdings LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of CTT Pharmaceutical Holdings's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CTT Pharmaceutical Holdings Inc (OTCPK:CTTH) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

1100 – 1111 Melville Street, Vancouver, BC, CAN, V6E 3V6

Website

https://www.cttpharmaceuticals.com

CTT Pharmaceutical Holdings Inc is a development stage company specializing in drug delivery systems technology within the pharmaceutical industry. It focuses on fast-dissolving drug delivery systems through the development of oral delivery thin wafers. The thin wafers are infused with both natural and synthetic cannabis extracts to deliver treatment as an alternative to smoking and ingestion. Its products include Medwafe, Cannawafe, Vetwafe, and others.

Executives